Optimism over vaccines administered via mucosal surfaces

Multiomic analysis identifies glutaminolysis-dependent metabolic enhancement of immune memory utilised for vaccine development.

Nature communications·2026

Dysregulation of macrophage PEPD in obesity determines adipose tissue fibro-inflammation and insulin resistance.

Nature metabolism·2022

Three phylogenetic groups have driven the recent population expansion of Cryptococcus neoformans.

Nature communications·2019

Point-prevalence survey of carbapenemase-producing Enterobacteriaceae and vancomycin-resistant enterococci in adult inpatients in a university teaching hospital in the UK.

The Journal of hospital infection·2018

Erratum: Antimicrobial resistance in human populations: challenges and opportunities - ERRATUM.

Global health, epidemiology and genomics·2018

Antimicrobial resistance in human populations: challenges and opportunities.

Global health, epidemiology and genomics·2017

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Enhancing public health intelligence workforce capacity and capability: insights from English local authorities' COVID-19 response.

Frontiers in public health·2026

Mapping Policy Gaps and Governance Challenges in Kenya's Hand Hygiene Environment: A Health Policy Triangle Analysis.

Health policy and planning·2026

Community-Based Mental Health Promotion and Public Policy Integration: A Scoping Review (1990-2024).

Healthcare (Basel, Switzerland)·2026

Nursing Interventions to Promote Health Literacy in Children and Adolescents: A Scoping Review.

Healthcare (Basel, Switzerland)·2026

Toward a 'Holistic' Approach to Promoting Physical and Mental Health in Children and Adolescents Through Physical Activity.

Acta paediatrica (Oslo, Norway : 1992)·2026

Perceived effectiveness of factors and intervention strategies for promoting evidence-based policymaking in Japan: a cross-sectional survey among policymakers, researchers and knowledge brokers.

Health research policy and systems·2026

Related Experiment Videos

Optimism over vaccines administered via mucosal surfaces

Related Concept Videos

Multiomic analysis identifies glutaminolysis-dependent metabolic enhancement of immune memory utilised for vaccine development.

Dysregulation of macrophage PEPD in obesity determines adipose tissue fibro-inflammation and insulin resistance.

Three phylogenetic groups have driven the recent population expansion of Cryptococcus neoformans.

Point-prevalence survey of carbapenemase-producing Enterobacteriaceae and vancomycin-resistant enterococci in adult inpatients in a university teaching hospital in the UK.

Erratum: Antimicrobial resistance in human populations: challenges and opportunities - ERRATUM.

Antimicrobial resistance in human populations: challenges and opportunities.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Enhancing public health intelligence workforce capacity and capability: insights from English local authorities' COVID-19 response.

Mapping Policy Gaps and Governance Challenges in Kenya's Hand Hygiene Environment: A Health Policy Triangle Analysis.

Community-Based Mental Health Promotion and Public Policy Integration: A Scoping Review (1990-2024).

Nursing Interventions to Promote Health Literacy in Children and Adolescents: A Scoping Review.

Toward a 'Holistic' Approach to Promoting Physical and Mental Health in Children and Adolescents Through Physical Activity.

Perceived effectiveness of factors and intervention strategies for promoting evidence-based policymaking in Japan: a cross-sectional survey among policymakers, researchers and knowledge brokers.

Related Experiment Videos

Optimism over vaccines administered via mucosal surfaces

Related Concept Videos

Related Articles